2000
DOI: 10.1007/s100169910040
|View full text |Cite
|
Sign up to set email alerts
|

Endovascular Grafts in the Treatment of Thoracic Aortic Aneurysms and Pseudoaneurysms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
44
0
9

Year Published

2004
2004
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(56 citation statements)
references
References 16 publications
3
44
0
9
Order By: Relevance
“…Overall, successful device deployment is achieved in 85% to 100% of cases, and periprocedural mortality ranges from 0% to 14%, falling within or below elective surgery mortality rates of 5% to 20%. 68,[75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90] As expected, outcomes have improved over time with accumulated technical expertise, use of commercially manufactured devices, and improved patient selection criteria. The recently published collective experiences of the EUROSTAR and United Kingdom Thoracic Endograft registries, the largest series to date (nϭ249), demonstrate successful deployment in 87% of cases, 30-day mortality of 5% for elective cases, and paraplegia and endoleak rates of 4%.…”
Section: Clinical Experiencementioning
confidence: 99%
“…Overall, successful device deployment is achieved in 85% to 100% of cases, and periprocedural mortality ranges from 0% to 14%, falling within or below elective surgery mortality rates of 5% to 20%. 68,[75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90] As expected, outcomes have improved over time with accumulated technical expertise, use of commercially manufactured devices, and improved patient selection criteria. The recently published collective experiences of the EUROSTAR and United Kingdom Thoracic Endograft registries, the largest series to date (nϭ249), demonstrate successful deployment in 87% of cases, 30-day mortality of 5% for elective cases, and paraplegia and endoleak rates of 4%.…”
Section: Clinical Experiencementioning
confidence: 99%
“…En los últimos años el desarrollo de las técnicas endovasculares para el tratamiento de aneurismas y otras lesiones crónicas de la aorta torácica han permitido disminuir en forma considerable las cifras de morbi-mortalidad asociadas al manejo de estas lesiones [12][13][14] , lo que ha ocurrido también en nuestra experiencia 15,16 .…”
Section: Discussionunclassified
“…Esta complicación ha sido reportada ocasionalmente en el manejo endovascular electivo de aneurismas de la aorta descendente, con mucha menor frecuencia que en la cirugía abierta 12,13 . Incluso en series recientes de reparación endovascular de lesiones aneurismáticas en general, no se reportan casos de paraplejia 16,[24][25][26] o incidencias inferiores a 2,5% 27,28 .…”
Section: Discussionunclassified
“…In addition to aneurysms, a wide variety of diseases of the thoracic aorta have been treated with thoracic stent grafts: blunt traumatic aortic ruptures, complicated penetrating ulcers, acute and chronic type B dissections, mycotic aneurysms, iatrogenic aortic ruptures and other miscellaneous diseases (22)(23)(24)(25). Procedural success rates are greater than 95%, while in-hospital mortality is mainly linked to the severity of the patient's comorbidities (26,27). Baumgart et al (28) reported dismal early survival in patients with a poor clinical status (American Society of Anesthesiologists' classification higher than class 3).…”
Section: Thoracic Stent Graftingmentioning
confidence: 99%